In addition, BTN3A1 is dysregulated in different types of human cancer, including breast cancer, ovarian cancer, bladder cancer, renal cell carcinoma, and pancreatic ductal adenocarcinoma [14–17]. This evidence concerns the gene BTN3A1 and urinary bladder carcinoma.